According to the latest study from BCC Research, the "G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global ...

Amino acids play a fundamental role in regulating how cells respond to drugs. These molecules, which form proteins, act like ...

Evotec's insights into GPCRs and waveRAPID technology reveal new opportunities in drug discovery, focusing on orphan receptors and innovative screening methods.

Scientists have discovered novel drug candidates that could ultimately lead to new effective treatments for conditions caused ...

Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions caused by tissue stress and inflammation, including neuropathic pain and ...

Collaboration combines Novo Nordisk’s scientific leadership in obesity and cardiometabolic diseases with Septerna’s expertise in G protein-coupled receptor (GPCR) drug discovery Goal is to ...

About one-third of drugs approved by the US Food and Drug Administration (FDA) target GPCRs, according to Novo Nordisk.

The two companies have further agreed to make their combined technology platforms commercially available to the drug discovery community specializing in GPCR and other targets.

OMS1620 is advancing through IND-enabling studies for diseases associated with ACTH excess, including congenital adrenal ...

Oxford, United Kingdom - 7th July 2025 - OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying ...